Abstract
Faropenem was tested against 1,188 middle ear fluid pathogens from children in Israel and Costa Rica. Against Streptococcus pneumoniae and Haemophilus influenzae, faropenem was the most active beta-lactam, with activity that was similar to or greater than of the other oral antimicrobial classes studied. Faropenem was also active against Moraxella catarrhalis and Streptococcus pyogenes.
MeSH terms
-
Acute Disease
-
Anti-Bacterial Agents / pharmacology*
-
Child
-
Costa Rica
-
Ear, Middle / microbiology*
-
Haemophilus influenzae / drug effects*
-
Humans
-
Israel
-
Microbial Sensitivity Tests / methods
-
Moraxella catarrhalis / drug effects
-
Otitis Media with Effusion / microbiology*
-
Streptococcus pneumoniae / drug effects*
-
Streptococcus pyogenes / drug effects
-
beta-Lactams / pharmacology*
Substances
-
Anti-Bacterial Agents
-
beta-Lactams
-
fropenem